Which has the lower trailing P/E, BIO or OSCR?

OSCR has the lower trailing P/E: BIO trades at 45.63 and OSCR at 22.95. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, BIO or OSCR?

Over the past five years, OSCR grew revenue faster — BIO at a 0.29% CAGR versus OSCR at 64.83%.

Is BIO or OSCR more profitable?

BIO runs the higher net margin — BIO at 8.59% versus OSCR at 3.60%.

How have BIO and OSCR total returns compared?

Over the past 5 years, BIO delivered -14.74% and OSCR delivered 13.36% annualized total return. Past performance doesn't predict future results.

Bio-Rad Laboratories, Inc. (BIO) vs Oscar Health, Inc. (OSCR)

A side-by-side comparison of Bio-Rad Laboratories, Inc. and Oscar Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

BIO

Bio-Rad Laboratories, Inc.

$10.13B

$376.41HealthcareDelayed quote: Sep 18, 2026, 4:00 PM EDT

OSCR

Oscar Health, Inc.

$8.33B

$32.13HealthcareDelayed quote: Sep 18, 2026, 4:00 PM EDT

Total return — BIO vs OSCR

growth of $100 · dividends reinvested · last 6y

BIO -34.8% (-6.9%/yr)OSCR -5.8% (-1.0%/yr)OSCR compounded faster over this window

BIO OSCR

BIO vs OSCR: by the numbers

•BIO is the larger company ($10.13B vs $8.33B market cap).
•OSCR trades at the lower trailing earnings multiple (22.95 vs 45.63 P/E), one valuation lens rather than an overall verdict.
•BIO converts more revenue to profit (8.59% vs 3.60% net margin).
•OSCR grew revenue faster over the past five years (64.83% vs 0.29% CAGR).

Metrics side by side

Valuation

Metric	BIO	OSCR
P/E ratio	45.63	22.95
Forward P/E	39.04	18.64
P/S ratio	3.91	0.54
P/B ratio	1.41	4.06
EV / EBITDA	28.28	7.18
FCF yield	3.49%	52.04%

Profitability

Metric	BIO	OSCR
Gross margin	51.90%	14.38%
Operating margin	9.08%	4.07%
Net margin	8.59%	3.60%
ROE	3.10%	26.84%
ROIC	1.54%	22.98%

Growth (annualized)

Metric	BIO	OSCR
Revenue CAGR (5Y)	0.29%	64.83%
EPS CAGR (5Y)	-26.27%	N/A
FCF CAGR (5Y)	-9.65%	80.81%
Total return CAGR (5Y)	-14.74%	13.36%

Frequently asked

Which has the lower trailing P/E, BIO or OSCR?: OSCR has the lower trailing P/E: BIO trades at 45.63 and OSCR at 22.95. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, BIO or OSCR?: Over the past five years, OSCR grew revenue faster — BIO at a 0.29% CAGR versus OSCR at 64.83%.
Is BIO or OSCR more profitable?: BIO runs the higher net margin — BIO at 8.59% versus OSCR at 3.60%.
How have BIO and OSCR total returns compared?: Over the past 5 years, BIO delivered -14.74% and OSCR delivered 13.36% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BIO analysis Full OSCR analysis Interactive comparison tool

Dig into the metrics

Bio-Rad Laboratories P/E ratio Oscar Health P/E ratio Bio-Rad Laboratories ROE Oscar Health ROE Bio-Rad Laboratories operating margin Oscar Health operating margin Bio-Rad Laboratories revenue growth Oscar Health revenue growth Bio-Rad Laboratories free cash flow Oscar Health free cash flow

Bio-Rad Laboratories & Oscar Health appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.